These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 31551193)
1. Safety of a New Subcutaneous Testosterone Enanthate Auto-Injector: Results of a 26-Week Study. Gittelman M; Jaffe JS; Kaminetsky JC J Sex Med; 2019 Nov; 16(11):1741-1748. PubMed ID: 31551193 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Outcomes for Hypogonadal Men Treated with Intramuscular Testosterone Cypionate versus Subcutaneous Testosterone Enanthate. Choi EJ; Xu P; Barham D; El-Khatib FM; Yafi FA; Kavoussi PK J Urol; 2022 Mar; 207(3):677-683. PubMed ID: 34694927 [TBL] [Abstract][Full Text] [Related]
3. A 52-Week Study of Dose Adjusted Subcutaneous Testosterone Enanthate in Oil Self-Administered via Disposable Auto-Injector. Kaminetsky JC; McCullough A; Hwang K; Jaffe JS; Wang C; Swerdloff RS J Urol; 2019 Mar; 201(3):587-594. PubMed ID: 30296416 [TBL] [Abstract][Full Text] [Related]
4. Summative Usability Evaluation of the SCTE-AI Device: A Novel Prefilled Autoinjector for Subcutaneous Testosterone Administration. Arora S; Moclair B; Murphy K; Jaffe JS; Kaminetsky JC J Sex Med; 2018 Dec; 15(12):1707-1715. PubMed ID: 30393104 [TBL] [Abstract][Full Text] [Related]
5. Post-market safety and efficacy profile of subcutaneous testosterone enanthate-autoinjector: a cohort analysis. Choi EJ; Xu P; El-Khatib FM; Kavoussi PK; Yafi FA Int J Impot Res; 2022 Aug; 34(5):467-470. PubMed ID: 34007063 [TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men. Arver S; Dobs AS; Meikle AW; Caramelli KE; Rajaram L; Sanders SW; Mazer NA Clin Endocrinol (Oxf); 1997 Dec; 47(6):727-37. PubMed ID: 9497881 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic Profile of Subcutaneous Testosterone Enanthate Delivered via a Novel, Prefilled Single-Use Autoinjector: A Phase II Study. Kaminetsky J; Jaffe JS; Swerdloff RS Sex Med; 2015 Dec; 3(4):269-79. PubMed ID: 26797061 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, Clinical Efficacy, Safety Profile, and Patient-Reported Outcomes in Patients Receiving Subcutaneous Testosterone Pellets 900 mg for Treatment of Symptoms Associated With Androgen Deficiency. McMahon CG; Shusterman N; Cohen B J Sex Med; 2017 Jul; 14(7):883-890. PubMed ID: 28673432 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and safety of long-acting testosterone undecanoate injections in hypogonadal men: an 84-week phase III clinical trial. Wang C; Harnett M; Dobs AS; Swerdloff RS J Androl; 2010; 31(5):457-65. PubMed ID: 20133964 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate--a clinical research center study. Salehian B; Wang C; Alexander G; Davidson T; McDonald V; Berman N; Dudley RE; Ziel F; Swerdloff RS J Clin Endocrinol Metab; 1995 Dec; 80(12):3567-75. PubMed ID: 8530600 [TBL] [Abstract][Full Text] [Related]
11. Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism. Schubert M; Minnemann T; Hübler D; Rouskova D; Christoph A; Oettel M; Ernst M; Mellinger U; Krone W; Jockenhövel F J Clin Endocrinol Metab; 2004 Nov; 89(11):5429-34. PubMed ID: 15531493 [TBL] [Abstract][Full Text] [Related]
12. A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men. Swerdloff RS; Wang C; White WB; Kaminetsky J; Gittelman MC; Longstreth JA; Dudley RE; Danoff TM J Clin Endocrinol Metab; 2020 Aug; 105(8):2515-31. PubMed ID: 32382745 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of a new testosterone-in-adhesive matrix patch applied every 2 days for 1 year to hypogonadal men. Raynaud JP; Legros JJ; Rollet J; Augès M; Bunouf P; Sournac M; Fiet J J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):168-76. PubMed ID: 18325757 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. Dobs AS; Meikle AW; Arver S; Sanders SW; Caramelli KE; Mazer NA J Clin Endocrinol Metab; 1999 Oct; 84(10):3469-78. PubMed ID: 10522982 [TBL] [Abstract][Full Text] [Related]
15. Two-Year Analysis of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men: Efficacy, Impact on Psychosexual Function, and Safety. Honig S; Gittelman M; Kaminetsky J; Wang C; Amory JK; Rohowsky N; Dudley RE; Woun Seo B; Newmark J; Swerdloff R J Sex Med; 2022 Dec; 19(12):1750-1758. PubMed ID: 36272969 [TBL] [Abstract][Full Text] [Related]
16. Retrospective investigation of testosterone undecanoate depot for the long-term treatment of male hypogonadism in clinical practice. Conaglen HM; Paul RG; Yarndley T; Kamp J; Elston MS; Conaglen JV J Sex Med; 2014 Feb; 11(2):574-82. PubMed ID: 24279472 [TBL] [Abstract][Full Text] [Related]
17. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study. von Eckardstein S; Nieschlag E J Androl; 2002; 23(3):419-25. PubMed ID: 12002444 [TBL] [Abstract][Full Text] [Related]
18. Ambulatory Blood Pressure Parameters Among Men With Hypogonadism Treated With Testosterone Transdermal Therapy. Efros MD; Kaminetsky JC; Sherman ND; Chan A; Thomas JW Endocr Pract; 2024 Sep; 30(9):847-853. PubMed ID: 38876182 [TBL] [Abstract][Full Text] [Related]
19. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798 [TBL] [Abstract][Full Text] [Related]
20. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men. Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ J Androl; 1998; 19(6):761-8. PubMed ID: 9876028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]